BIO Investor Forum presenters are announced.

Press Release Summary:



BIO announced initial selection of presenting companies for tenth annual BIO Investor Forum, which will be held in San Francisco, CA on October 25-26 and focus on private as well as emerging public biotech companies. Forum aims to bring together biotech companies and investors to foster development of new medicines that will expand industry pipeline. Also, media and investor registration is now available.



Original Press Release:



BIO Announces Presenting Companies for 10th Annual BIO Investor Forum



BIO Investor Forum will be held October 25 - 26 in San Francisco, CA

WASHINGTON--The Biotechnology Industry Organization (BIO) today announces the initial selection of presenting companies for the 10th annual BIO Investor Forum to be held October 25 - 26 in San Francisco, CA. In its 10th year, this international investor conference focused on private and emerging public biotech companies celebrates a "Decade of Excellence."

"We pride ourselves on creating a unique environment where attendees from around the world come with the purpose of investing in private and early stage biotech companies. It is our hope that with the 10th annual BIO Investor Forum, attendees and presenters alike capitalize on the exceptional opportunities available only at this event," said Alan Eisenberg, Executive Vice President of Emerging Companies and Business Development at BIO.

The aim of the forum is to bring together a select group of private and early stage biotech companies and leading investors to foster the development of important new medicines that will expand the industry's pipeline. Investors attend to meet with executives from life sciences growth companies, benefit from candid panel discussions and get an overview of the industry. Companies attend to meet one-on-one with new and current investors, get the pulse on the latest life science investment trends and network with peers, investors and potential partners.

In addition to the announcement of presenting companies, media and investor registration is now available. Registration is complimentary for credentialed members of the media and qualified investors. To learn more about registration, media please visit here and investors please visit here.

The criterion for presenting companies was established by BIO and the conference advisory committee. The committee is comprised of members from top-tier firms focused on investing and banking in the life sciences industry in addition to executives from emerging and leading biotech companies.

As of today, the following companies are scheduled to present at this year's forum:

ADVENTRX Pharmaceuticals, Inc., ANX | News
Aegerion Pharmaceuticals, Inc., News
Aeolus Pharmaceuticals, OTC:AOLS | News
Allon Therapeutics Inc., NPC | News
Allozyne Inc., News
Anacor Pharmaceuticals, Inc., ANAC | News
Anaphore, Inc., News
Anchor Therapeutics, News
Ancora Pharmaceuticals Inc., News
Aquinox Pharmaceuticals Inc., News
Aradigm Corporation, OTC:ARDM | News
BioSante Pharmaceuticals, Inc., BPAX | News
Catabasis Pharmaceuticals, Inc., News
Catalyst Pharmaceutical Partners, Inc., CPRX | News
Cell Therapeutics, Inc., CTIC | News
CoMentis, Inc., News
Constellation Pharmaceuticals, News
Curis Inc., CRIS | News
Cyclacel Pharmaceuticals, Inc., CYCC | News
Dicerna Pharmaceuticals, Inc., News
Elusys Therapeutics, Inc., News
Epizyme, Inc., News
FasterCures - Patient Advocacy Group, News
Flexion Therapeutics, News
GATEKEEPER Pharmaceuticals, News
Genocea Biosciences, News
GenVec, Inc., GNVC | News
GlobeImmune Inc., News
HemaQuest Pharmaceuticals, Inc., News
Heptares Therapeutics, News
Ikaria, Inc., News
Immune Design Corp., News
Immunovaccine Inc., CVE:IMV | News
Inimex Pharmaceuticals Inc., News
Jennerex Biotherapeutics, Inc., News
KAI Pharmaceuticals, Inc., News
Kiadis Pharma, News
KineMed, Inc., News
LigoCyte Pharmaceuticals, Inc., News
Lipocine Inc., News
MabVax Therapeutics, Inc., News
MaxCyte, Inc., News
Mersana Therapeutics, Inc., News
Mirna Therapeutics Inc., News
Mithridion, Inc., News
Peregrine Pharmaceuticals, Inc., PPHM | News
PLx Pharma Inc., News
Probiodrug AG, News
Prosensa Therapeutics, News
Reata Pharmaceuticals Inc., News
Resverlogix Corp., RVX | News
Rib-X Pharmaceuticals, Inc., News
RXi Pharmaceuticals Corporation, RXII | News
Savara Inc., News
Senesco Technologies, Inc., SNT | News
Sorbent Therapeutics, Inc., News
Spinifex Pharmaceuticals, News
SuppreMol GmbH, News
Syndax Pharmaceuticals, Inc., News
Syntaxin Ltd., News
TESARO, News
Tetraphase Pharmaceuticals, News
Tobira Therapeutics, News
Tranzyme Pharma, TZYM | News
Trius Therapeutics, TSRX | News
Unigene Laboratories, Inc., OTC:UGNE | News
XOMA LLC, XOMA | News
Zalicus Inc., ZLCS | News
ZIOPHARM Oncology Inc., ZIOP | News
Zymeworks Inc., News

With the success of last year's inaugural "Discovery Track," BIO is pleased to announce the return of this program. "Discovery Track" features a select group of entrepreneurs who are first introducing their startup companies to the national investment community at the BIO Investor Forum. The following companies are scheduled to present:
A&G Pharmaceutical, Inc., News
Aciont Inc., News
Afraxis, News
Arbovax, Inc., News
Axikin Pharmaceuticals, News
Cebix Incorporated, News
CureFAKtor Pharmaceuticals, LLC, News
Cyterix Pharmaceuticals, Inc., News
Del Mar Pharmaceuticals, News
DLVR Therapeutics Inc., News
DNA Therapeutics SA, News
Edge Therapeutics, Inc., News
Envoy Therapeutics, News
Epiomed Therapeutics, Inc., News
Esperion Therapeutics, Inc., News
FluGen, Inc., News
Genprex, Inc., News
GlycoRegImmune, Inc., News
G-Zero Therapeutics, News
Immune Targeting Systems Ltd., News
ImmunoGenes AG, News
ImmusanT, Inc., News
Indel Therapeutics Inc., News
InVasc Therapeutics, Inc., News
Kareus Therapeutics, SA, News
Molecular Templates Inc., News
PharmaNeuroBoost, News
Sirius Genomics Inc., News
TxCell S.A., News

Check back often as new presenters are continuously being added. If you are interested in becoming a presenter, please submit an application here.

Upcoming BIO Events

BIO India International Partnering Conference
September 21-22, 2011
Hyderabad, India

BIO China International Conference
October 12-13, 2011
Shanghai, China

10th Annual BIO Investor Forum
October 25-26, 2011
San Francisco, Calif.

BIO-Europe 2011
October 31-November 2, 2011
Duesseldorf, Germany

BIO IP Counsels Committee Fall Conference & Meeting
November 2-4, 2011
New York, NY

BioMalaysia 2011 Conference & Exhibition/
2011 Pacific Rim Summit on Industrial Biotechnology and Bioenergy
November 21-23, 2011
Kuala Lumpur, Malaysia

About BIO

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, a multiblog platform and monthly newsletter that aims to create an online biotech community where the the industry can connect to discuss the latest news. Subscribe to BIOtechNOW.

For more information:
Visit www.bio.org
Follow us on Twitter @IAmBiotech
Join us on LinkedIn/MyBio
Become a fan at facebook.com/IAmBiotech

Contacts
Biotechnology Industry Organization (BIO)
Abigail Hirsch, 202-962-9235
ahirsch@bio.org

All Topics